医薬品添加剤 - 市場考察、競合情勢、市場予測（2030年）

世界の医薬品添加剤の市場規模は、2023年に91億8,000万米ドルであり、2030年までに141億2,000万米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで6.43％の成長が見込まれます。市場は、投資による医薬品製造への需要の高まり、医薬品の研究開発における最新の技術革新、バイオテクノロジー企業や製薬企業における添加剤の製品開発活動の活発化などにより大きく成長しており、これらが2024年～2030年に医薬品添加剤市場を牽引すると予測されます。

医薬品添加剤の市場力学

近年、製薬部門への投資が増加していることから、医薬品添加剤市場の成長に拍車がかかり、今後数年間の需要の増加が見込まれています。

例えば、Congressional Budget Office（2021年）のデータによると、米国における研究開発と新薬の導入への支出は過去20年間で大幅に増加しています。Pharmaceutical Research and Manufacturers of America（PhRMA）加盟企業の医薬品研究開発への民間投資は、1980年に約50億米ドル、2000年に380億米ドルでしたが、2019年に約830億米ドルとなっています。

また、欧州などの主要地域では、強力で競争の激しい製薬産業の市場が存在します。欧州委員会（2020年）のデータによると、医薬品メーカーは2019年の研究投資に370億ユーロの最大の寄与をしています。

欧州のHealth Emergency Response Authority（HERA）のような当局の存在は、添加剤を含む医薬品の研究、製造、開発への投資を通じて、全体的な医療インフラの強化に役立っています。

Atradius Industry Trends Pharmceuticals（2022年）の数字によると、インドなどのアジア太平洋の主要発展途上国では、パンデミックがインドの医薬品メーカーに研究開発費を決定的に強化するよう刺激しました。さらに、2020年のサプライチェーンの混乱により、インドの医薬品メーカーは医薬品有効成分（API）と医薬品添加剤の現地生産を増やすことに熱心です。

また、China Embassy Government（2022年）のデータによると、中国の研究開発（R&D）投資は急速に増加しています。National Bureau of Statisticsの予備的推計によると、2021年の研究開発への支出は14.2％増の2兆7,900億人民元となっています。同国の着実な経済回復と技術革新の勢いの増加により、同国の研究開発費は毎年7％を超える成長が見込まれています。

さまざまな国による医薬品部門への投資の増加は、より多くの医薬品の製造への需要を促進し、結果として2024年～2030年の予測期間に医薬品添加剤市場を牽引する見込みです。

しかし、添加剤に関連する汚染や副作用のリスク、新規添加剤の開発にかかる高いコストなどが、医薬品添加剤市場の成長を制限する主な要請要因として作用する可能性があります。

医薬品添加剤市場のセグメント分析

医薬品添加剤市場の機能性セグメントでは、結合剤カテゴリが2023年に大きな収益シェアを占めると予測されます。この製品カテゴリの急成長は、結合剤のさまざまな用途と、調査期間にこのカテゴリで行われている製品開発活動に起因するものと言えます。

医薬品の打錠は結合剤に大きく依存しています。結合剤は粉末の凝集性と柔軟性を高めるために使用され、それによって錠剤の加工性が向上し、製造中に錠剤が破損するリスクが低下します。

結合剤は、粉末に凝集性を与えるために錠剤に添加され、顆粒を作るのに不可欠な結合を可能にし、それが圧縮されると錠剤として知られるコンパクトな塊を形成します。言い換えれば、結合剤は錠剤の「硬さ」を実現するために必要です。製薬産業では、ポビドン、ヒドロキシプロピルセルロース、微結晶セルロース、ポリエチレングリコール、ゼラチン、デンプン、カルボマー、カルボキシメチルセルロースナトリウムなどのさまざまな結合剤を使用しています。

当レポートでは、世界の医薬品添加剤市場について調査分析し、各地域の市場規模と予測、過去3年間の製品/技術開発、各セグメントの業績と見通しなどの情報を提供しています。

目次

第1章 医薬品添加剤市場レポートのイントロダクション

第2章 医薬品添加剤市場のエグゼクティブサマリー

• 市場の概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 医薬品添加剤市場の主な要因の分析

• 医薬品添加剤市場の促進要因
• 医薬品添加剤市場の抑制要因と課題
• 医薬品添加剤市場の機会

第6章 医薬品添加剤市場のポーターのファイブフォース分析

第7章 医薬品添加剤市場の評価

• タイプ別
  • 有機化学品
  • 無機化学品
  • その他
• 用途別
  • 経口
  • 非経口
  • 外用
• 機能別
  • 賦形剤
  • 結合剤
  • コーティング、着色剤
  • 香料
  • 防腐剤
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 医薬品添加剤市場の企業と製品のプロファイル

• BASF SE
• ADM
• DuPont
• Croda International PLC
• Kerry
• Roquette Freres
• Ashland
• Innophos
• Associated British Foods PLC
• The Lubrizol Corporation
• Evonik Industries AG
• Air Liquide
• DSM
• Merck KGaA
• Eastman Chemical Company
• Clariant
• Clyzo, Inc.
• SPI Pharma
• Lavina Pharmaceuticals Pvt. Ltd
• Freund Corporation

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Pharmaceutical Excipients Market in Global (2021-2030)
• Table 3: Pharmaceutical Excipients Market in Global by Type (2021-2030)
• Table 4: Pharmaceutical Excipients Market in Global by Application (2021-2030)
• Table 5: Pharmaceutical Excipients Market in Global by Functionality (2021-2030)
• Table 6: Pharmaceutical Excipients Market in Global by Geography (2021-2030)
• Table 7: Pharmaceutical Excipients Market in North America (2021-2030)
• Table 8: Pharmaceutical Excipients Market in the United States (2021-2030)
• Table 9: Pharmaceutical Excipients Market in Canada (2021-2030)
• Table 10: Pharmaceutical Excipients Market in Mexico (2021-2030)
• Table 11: Pharmaceutical Excipients Market in Europe (2021-2030)
• Table 12: Pharmaceutical Excipients Market in France (2021-2030)
• Table 13: Pharmaceutical Excipients Market in Germany (2021-2030)
• Table 14: Pharmaceutical Excipients Market in United Kingdom (2021-2030)
• Table 15: Pharmaceutical Excipients Market in Italy (2021-2030)
• Table 16: Pharmaceutical Excipients Market in Spain (2021-2030)
• Table 17: Pharmaceutical Excipients Market in the Rest of Europe (2021-2030)
• Table 18: Pharmaceutical Excipients Market in Asia-Pacific (2021-2030)
• Table 19: Pharmaceutical Excipients Market in China (2021-2030)
• Table 20: Pharmaceutical Excipients Market in Japan (2021-2030)
• Table 21: Pharmaceutical Excipients Market in India (2021-2030)
• Table 22: Pharmaceutical Excipients Market in Australia (2021-2030)
• Table 23: Pharmaceutical Excipients Market in South Korea (2021-2030)
• Table 24: Pharmaceutical Excipients Market in Rest of Asia-Pacific (2021-2030)
• Table 25: Pharmaceutical Excipients Market in the Rest of the World (2021-2030)
• Table 26: Pharmaceutical Excipients Market in the Middle East (2021-2030)
• Table 27: Pharmaceutical Excipients Market in Africa (2021-2030)
• Table 28: Pharmaceutical Excipients Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Pharmaceutical Excipients Market in Global (2021-2030)
• Figure 3: Pharmaceutical Excipients Market in Global by Type (2021-2030)
• Figure 4: Pharmaceutical Excipients Market in Global by Application (2021-2030)
• Figure 5: Pharmaceutical Excipients Market in Global by Functionality (2021-2030)
• Figure 6: Pharmaceutical Excipients Market in Global by Geography (2021-2030)
• Figure 7: Pharmaceutical Excipients Market in North America (2021-2030)
• Figure 8: Pharmaceutical Excipients Market in the United States (2021-2030)
• Figure 9: Pharmaceutical Excipients Market in Canada (2021-2030)
• Figure 10: Pharmaceutical Excipients Market in Mexico (2021-2030)
• Figure 11: Pharmaceutical Excipients Market in Europe (2021-2030)
• Figure 12: Pharmaceutical Excipients Market in France (2021-2030)
• Figure 13: Pharmaceutical Excipients Market in Germany (2021-2030)
• Figure 14: Pharmaceutical Excipients Market in United Kingdom (2021-2030)
• Figure 15: Pharmaceutical Excipients Market in Italy (2021-2030)
• Figure 16: Pharmaceutical Excipients Market in Spain (2021-2030)
• Figure 17: Pharmaceutical Excipients Market in the Rest of Europe (2021-2030)
• Figure 18: Pharmaceutical Excipients Market in Asia-Pacific (2021-2030)
• Figure 19: Pharmaceutical Excipients Market in China (2021-2030)
• Figure 20: Pharmaceutical Excipients Market in Japan (2021-2030)
• Figure 21: Pharmaceutical Excipients Market in India (2021-2030)
• Figure 22: Pharmaceutical Excipients Market in Australia (2021-2030)
• Figure 23: Pharmaceutical Excipients Market in South Korea (2021-2030)
• Figure 24: Pharmaceutical Excipients Market in Rest of Asia-Pacific (2021-2030)
• Figure 25: Pharmaceutical Excipients Market in the Rest of the World (2021-2030)
• Figure 26: Pharmaceutical Excipients Market in the Middle East (2021-2030)
• Figure 27: Pharmaceutical Excipients Market in Africa (2021-2030)
• Figure 28: Pharmaceutical Excipients Market in South America (2021-2030)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Pharmaceutical Excipients Market by Type (Organic Chemicals, Inorganic Chemicals, and Others), Application (Oral, Parenteral, and Topical), Functionality (Fillers, Binders, Coatings and Colorants, Flavouring Agents, Preservatives, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 due to the rising demand for pharmaceutical manufacturing owing to investments and the latest innovations in pharmaceutical research and development activities across the globe.

The Pharmaceutical Excipients market was valued at USD 9.18 billion in 2023, growing at a CAGR of 6.43% during the forecast period from 2024 to 2030 to reach USD 14.12 billion by 2030. The Pharmaceutical Excipients market is growing significantly due to the rising demand for pharmaceutical manufacturing owing to investments, the latest innovations in the research and development of pharmaceuticals, and the growing number of product development activities for excipients among biotech companies and pharmaceutical firms, among others that are expected to drive the Pharmaceutical Excipients market from 2024 to 2030.

Pharmaceutical Excipients Market Dynamics:

In recent years, the increasing investments in the pharmaceutical sector is expected to spur the market growth for pharmaceutical excipients, which is expected to increase their demand in the coming years.

For example, as per data by the Congressional Budget Office (2021), spending on Research and Development and the introduction of new drugs in the US had substantially increased in the past two decades. The private investment in drug R&D among member firms of the Pharmaceutical Research and Manufacturers of America (PhRMA), was about USD 83 billion in 2019, up from about USD 5 billion in 1980 and USD 38 billion in 2000.

Also, in major regions such as Europe, there is a strong and competitive pharmaceutical industrial market. As per data by the European Commission (2020), medicine producers made the largest contribution of Euros 37 billion for research investment in 2019.

Presence of authorities such as the European Health Emergency Response Authority (HERA) helps in the strengthening the overall healthcare infrastructure through investments in research, manufacturing, and development of drugs including excipients.

Figures by the Atradius Industry Trends Pharmceuticals (2022) highlight that in major developing countries in the Asia-Pacific such as India, the pandemic spurred the Indian drug producers to crucially enhance their R&D spending. Moreover, due to the supply chain disruption in 2020, Indian drug producers are keen on increasing the local production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical excipients.

Also as per data by the China Embassy Government (2022), China's investment on research and development (R&D) is growing rapidly. The country's spending on R&D climbed to 14.2 percent to 2.79 trillion RMB in 2021, according to preliminary estimates of the National Bureau of Statistics. Owing to the country's steady economic recovery and increasing innovation momentum, the country's R&D spending is expected to grow by more than seven percent every year.

The increasing investments in the pharmaceutical sector by the various countries shall propel the demand for more pharmaceutical manufacturing, thus ultimately driving the market for pharmaceutical excipients during the given forecast period from 2024 to 2030.

However, the risk of contamination and adverse reactions associated with excipients, and the high cost of development of novel excipients, among others may act as key constraints limiting the growth of the pharmaceutical excipients market.

Pharmaceutical Excipients Market Segment Analysis:

Pharmaceutical Excipients Market by Type (Organic Chemicals, Inorganic Chemicals, and Others), Application (Oral, Parenteral, and Topical), Functionality (Fillers, Binders, Coatings and Colorants, Flavouring Agents, Preservatives, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the functionality segment of the pharmaceutical excipients market, the binders category is expected to have a significant revenue share in the year 2023. The rapid growth of this product category can be attributed to the various applications of binders and the product development activities taking place in this category during the study period.

Pharmaceutical tableting relies heavily on binders. They are used to increase the cohesiveness and flexibility of the powder combination, hence increasing tablet processability and lowering the risk of tablet breakage during manufacturing.

Binders are added to tablet formulations to provide cohesiveness to powders, allowing the essential bonding to create granules, which when compacted form a compact mass known as a tablet. In other words, binders are required to achieve the tablet's "hardness". The pharmaceutical industry uses a wide range of binder excipients, including povidone, hydroxypropyl cellulose, microcrystalline cellulose, polyethylene glycol, gelatin, starch, carbomers, and sodium carboxymethyl cellulose, among others.

Binders are typically chosen based on prior experience, specific product requirements, or the preferences of individual scientists or manufacturing units. The fundamental criterion for selecting a binder is compatibility with other tablet components.

Additionally, the introduction of technologically improved and new products also propels the market for this category's growth. For example, in October 2021, Beneo introduced galenIQ 721, a filler binder that enhanced the flavor and stability of effervescent tablets and powders. It is a non-hygroscopic, water-soluble, and immediately compressible excipient, resulting in high content consistency and manufacturing efficiency in effervescent applications.

Therefore, owing to all the above-mentioned factors, the demand for binders upsurges, thereby the category is expected to witness considerable growth, thus contributing to the overall growth of the pharmaceutical excipients market during the forecast period.

North America is expected to dominate the overall Pharmaceutical Excipients market:

Among all the regions, North America is expected to dominate the pharmaceutical excipients market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to the growing market for pharmaceuticals, increasing investments in the research and development sector for the pharmaceutical industry along with the product development activities taking place in North America.

According to data by the National Association of Manufacturers (2021), pharmaceutical manufacturing is primarily essential to America's health and well-being and to the success of their economy.

The source further stated that the pharmaceutical and medicine manufacturing generates nearly USD 339 billion in output, directly employing an estimated 267,000 workers in the United States and supporting nearly 1.9 million more jobs across the country.

In addition as per data by the Congressional Budget Office (2021), it found that the pharmaceutical industry devoted USD 83 billion to R&D expenditures in 2019. The expenditures covered a variety of activities, including discovering and testing new drugs, developing incremental innovations, and clinical testing for safety-monitoring purposes. The US pharmaceutical industry invests on average roughly three times more in R&D as a percentage of sales than all other manufacturing industries.

The growing pharmaceutical industry along with increasing investments in R&D would spur the market demand for pharmaceutical excipients to be used for manufacturing, presenting a conducive growth environment for the pharmaceutical excipients market in the forthcoming years.

Moreover, in January 2022, Lubrizol Life Science (LLS) Health, a global leader in accelerating success and innovation in pharmaceutical research, introduced Apisolex in the United States. It is a new solubility-enhancing excipient for parenteral medication formulations. This approach overcomes solubility barriers that cannot be addressed by conventional excipients or production methods.

Therefore, the interplay of all the aforementioned factors would drive the North American pharmaceutical excipients market during the forecast period.

Pharmaceutical Excipients Market key players:

Some of the key market players operating in the Pharmaceutical Excipients market include BASF SE, ADM, DuPont, Croda International PLC, Kerry, Roquette Freres, Ashland, Innophos, Associated British Foods PLC, The Lubrizol Corporation, Evonik Industries AG, Air Liquide, DSM, Merck KGaA, Eastman Chemical Company, Clariant, Clyzo, Inc., SPI Pharma, Lavina Pharmaceuticals Pvt. Ltd, Freund Corporation, and others.

Recent Developmental Activities in the Pharmaceutical Excipients Market:

• In November 2023, IFF's and BASF's Pharma Solutions divisions collaborated to bring IFF's leading product brands in pharmaceutical excipients to BASF's Virtual Pharma Assistant platform - ZoomLab(TM). The platform is a science-based digital technology developed to quickly and accurately forecast the appropriate excipients required for the production of new pharmaceutical formulations, thereby overcoming formulation problems. ZoomLab(TM), powered by BASF's unique technology, helps formulators accelerate formulation design by predicting the most effective excipients for a specific active pharmaceutical ingredient. It also allows customers to create adjustments, with a variety of substances to choose from, including IFF's well-known high-quality excipients.
• In October 2023, Clariant announced new additions to its portfolio of high-performing pharmaceutical ingredient solutions to support the evolution of safe and effective medicines. Clariant launched three new VitiPure(R) excipients allowing for a multitude of Active Pharmaceutical Ingredient (API) formulations and administration routes.
• In January 2022, DFE Pharma expanded its nutraceutical offering with the introduction of three starch-based excipients; namely Nutrofeli ST100, Nutrofeli ST200, and Nutrofeli ST300 that are naturally derived, versatile excipients that can be utilized as binders, fillers, and other uses for oral solid dosage forms while adhering to food and pharmaceutical guidelines.

Key Takeaways from the Pharmaceutical Excipients Market Report Study

• Market size analysis for current pharmaceutical excipients market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.
• Key companies dominating the pharmaceutical excipients market
• Various opportunities available for the other competitors in the pharmaceutical excipients market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current pharmaceutical excipients market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for pharmaceutical excipients market growth in the coming future?

Target audience who can be benefited from this pharmaceutical excipients Market Report Study

• Pharmaceutical excipients product providers
• Research organizations and consulting companies
• Pharmaceutical excipients-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in pharmaceutical excipients
• Various end-users who want to know more about the pharmaceutical excipients market and the latest developments in the pharmaceutical excipients market

Frequently Asked Questions for the Pharmaceutical Excipients Market:

1. What are Pharmaceutical Excipients?

Pharmaceutical excipients are compounds other than the active pharmaceutical ingredient (API) that have been thoroughly tested for safety and are purposefully used in a medication delivery system.

2. What is the market for Pharmaceutical Excipients?

The Pharmaceutical Excipients market was valued at USD 9.18 billion in 2023, growing at a CAGR of 6.43% during the forecast period from 2024 to 2030 to reach USD 14.12 billion by 2030.

3. What are the drivers for the Pharmaceutical Excipients market?

The Pharmaceutical Excipients market is growing significantly due to the rising demand for pharmaceutical manufacturing owing to investments, the latest innovations in the research and development of pharmaceuticals, and the growing number of product development activities for excipients among biotech companies and pharmaceutical firms, among others that are expected to drive the pharmaceutical excipients market from 2024 to 2030.

4. Who are the key players operating in the Pharmaceutical Excipients market?

Some of the key market players operating in the Pharmaceutical Excipients market include BASF SE, ADM, DuPont, Croda International PLC, Kerry, Roquette Freres, Ashland, Innophos, Associated British Foods PLC, The Lubrizol Corporation, Evonik Industries AG, Air Liquide, DSM, Merck KGaA, Eastman Chemical Company, Clariant, Clyzo, Inc., SPI Pharma, Lavina Pharmaceuticals Pvt. Ltd, Freund Corporation, and others.

5. Which region has the highest share in the Pharmaceutical Excipients market?

Among all the regions, North America is estimated to hold a significant revenue share in the Pharmaceutical Excipients market. This can be attributed to the growing market for pharmaceuticals, increasing investments in the research and development sector for the pharmaceutical industry along with the product development activities taking place in North America.

Table of Contents

1. Pharmaceutical Excipients Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Pharmaceutical Excipients Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Pharmaceutical Excipients Market Key Factors Analysis

• 5.1. Pharmaceutical Excipients Market Drivers
  • 5.1.1. Rising demand for pharmaceutical manufacturing owing to investments
  • 5.1.2. Latest innovations in the research and development of pharmaceuticals
  • 5.1.3. Growing number of product development activities for excipients among biotech companies and pharmaceutical firms
• 5.2. Pharmaceutical Excipients Market Restraints and Challenges
  • 5.2.1. Risk of contamination and adverse reactions associated with excipients
  • 5.2.2. High cost of development of novel excipients
• 5.3. Pharmaceutical Excipients Market Opportunities
  • 5.3.1. Rising developments in nanotechnology for the pharmaceutical excipients industry

6. Pharmaceutical Excipients Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Pharmaceutical Excipients Market Assessment

• 7.1. By Type
  • 7.1.1. Organic Chemicals
  • 7.1.2. Inorganic Chemicals
  • 7.1.3. Others
• 7.2. By Application
  • 7.2.1. Oral
  • 7.2.2. Parenteral
  • 7.2.3. Topical
• 7.3. By Functionality
  • 7.3.1. Fillers
  • 7.3.2. Binders
  • 7.3.3. Coatings and Colorants
  • 7.3.4. Flavouring Agents
  • 7.3.5. Preservatives
  • 7.3.6. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Pharmaceutical Excipients Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Pharmaceutical Excipients Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.3.3. India Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Pharmaceutical Excipients Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Pharmaceutical Excipients Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Pharmaceutical Excipients Market Size in USD million (2021-2030)

8. Pharmaceutical Excipients Market Company and Product Profiles

• 8.1. BASF SE
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. ADM
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. DuPont
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Croda International PLC
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Kerry
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Roquette Freres
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Ashland
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Innophos
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Associated British Foods PLC
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. The Lubrizol Corporation
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Evonik Industries AG
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Air Liquide
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. DSM
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Merck KGaA
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Eastman Chemical Company
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Clariant
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Clyzo, Inc.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. SPI Pharma
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Lavina Pharmaceuticals Pvt. Ltd
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Freund Corporation
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us